Arcadia Biosciences Q3 2023 revenue $1.6M, net loss $2.6M, launches GoodWheat Mac & Cheese

Arcadia Biosciences, Inc.

2023-Q3 EPS reported -$9.31 revenue$4,160,000

Revenue from continuing ops $1.597M, up 20% QoQ; net loss $2.567M ($1.89/sh) vs $2.867M ($4.67/sh) in Q3 2022.
GoodWheat Mac & Cheese launching in three varieties; shipping to retailers Nov 2023, e-commerce Feb 2024.
SG&A expenses $3.443M, lowest since 2019, down from $4.178M in Q3 2022.
Positive gross profit from continuing ops for seventh consecutive quarter; cash $10.6M, short-term investments $5.1M.
Nine-month net loss $11.128M ($9.31/sh) vs $11.132M ($19.37/sh) a year ago; weighted shares 1.195M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Arcadia Biosciences, Inc. reported the third quarter ended September 30, 2023 results: revenue 1,597, net income (2,567), EPS $1.89 per share.

Period: the third quarter ended September 30, 2023
Revenue: 1,597
Net income: (2,567)
EPS: $1.89 per share
Result: reported results

Exact text from the filing

($ in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 Favorable / (Unfavorable) 2023 2022 Favorable / (Unfavorable) $ % $ % Total revenues 1,597 1,570 27 2% 4,160 6,674 (2,514) (38%) Total operating expenses 4,839 5,561 722 13% 14,734 16,023 1,289 8% Loss from continuing operations (3,242) (3,991) 749 19% (10,574) (9,349)

View on SEC.gov

Browse all earnings releases →

Arcadia Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-062038

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.